{"id":"https://openalex.org/W2320023918","doi":"https://doi.org/10.1097/mol.0b013e3283404ff1","title":"Therapy and clinical trials: fibrate therapy in type 2 diabetes \u2013 where are we now?","display_name":"Therapy and clinical trials: fibrate therapy in type 2 diabetes \u2013 where are we now?","publication_year":2010,"publication_date":"2010-11-11","ids":{"openalex":"https://openalex.org/W2320023918","doi":"https://doi.org/10.1097/mol.0b013e3283404ff1","mag":"2320023918","pmid":"https://pubmed.ncbi.nlm.nih.gov/21206346"},"language":"en","primary_location":{"id":"doi:10.1097/mol.0b013e3283404ff1","doi":"https://doi.org/10.1097/mol.0b013e3283404ff1","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mol.0b013e3283404ff1","pdf_url":null,"source":{"id":"https://openalex.org/S203964698","display_name":"Current Opinion in Lipidology","issn_l":"0957-9672","issn":["0957-9672","1473-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Lipidology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103905887","display_name":"Rajesh Peter","orcid":"https://orcid.org/0009-0008-1671-627X","observed_orcids":["https://orcid.org/0009-0008-1671-627X"]},"institutions":[{"id":"https://openalex.org/I2802045936","display_name":"Neath Port Talbot Hospital","ror":"https://ror.org/04t6q1p67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1294711689","https://openalex.org/I2802045936"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Rajesh Peter","raw_affiliation_strings":["Neath Port Talbot Hospital, Abertawe Bro Morgannwg University Health Board, Port Talbot, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neath Port Talbot Hospital, Abertawe Bro Morgannwg University Health Board, Port Talbot, UK","institution_ids":["https://openalex.org/I2802045936"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080425152","display_name":"Elizabeth Reilly","orcid":"https://orcid.org/0000-0001-9619-226X","observed_orcids":["https://orcid.org/0000-0001-9619-226X"]},"institutions":[{"id":"https://openalex.org/I2802045936","display_name":"Neath Port Talbot Hospital","ror":"https://ror.org/04t6q1p67","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1294711689","https://openalex.org/I2802045936"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Reilly","raw_affiliation_strings":["Neath Port Talbot Hospital, Abertawe Bro Morgannwg University Health Board, Port Talbot, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neath Port Talbot Hospital, Abertawe Bro Morgannwg University Health Board, Port Talbot, UK","institution_ids":["https://openalex.org/I2802045936"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103470027","display_name":"Sony Anthony","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100558","display_name":"University Hospital of Hartlepool","ror":"https://ror.org/00z1y4j19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1299864998","https://openalex.org/I4210100558"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sony Anthony","raw_affiliation_strings":["University Hospital of Hartlepool, North Tees and Hartlepool NHS Trust, Hartlepool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Hartlepool, North Tees and Hartlepool NHS Trust, Hartlepool, UK","institution_ids":["https://openalex.org/I4210100558"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103905887"],"corresponding_institution_ids":["https://openalex.org/I2802045936"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"6","first_page":"554","last_page":"555"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.02669999934732914,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibrate-therapy","display_name":"fibrate therapy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6209999918937683},{"id":"https://openalex.org/keywords/triglyceride-lowering-agents","display_name":"triglyceride-lowering agents","score":0.625},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.7979999780654907},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.9136471748352051},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6625161170959473},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6229544878005981},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5414760708808899},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4033378064632416},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.334524929523468},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28827691078186035},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.09011268615722656},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.0803498923778534}],"mesh":[{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D058607","descriptor_name":"Fibric Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D058607","descriptor_name":"Fibric Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/mol.0b013e3283404ff1","doi":"https://doi.org/10.1097/mol.0b013e3283404ff1","is_oa":false,"landing_page_url":"https://doi.org/10.1097/mol.0b013e3283404ff1","pdf_url":null,"source":{"id":"https://openalex.org/S203964698","display_name":"Current Opinion in Lipidology","issn_l":"0957-9672","issn":["0957-9672","1473-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Lipidology","raw_type":"journal-article"},{"id":"pmid:21206346","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21206346","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in lipidology","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1966271903","https://openalex.org/W1971213885","https://openalex.org/W2007582789","https://openalex.org/W2128536064","https://openalex.org/W2137489898","https://openalex.org/W2164324917","https://openalex.org/W2198678228","https://openalex.org/W2219384223"],"related_works":["https://openalex.org/W4389918328","https://openalex.org/W188445981","https://openalex.org/W4234291388","https://openalex.org/W2894415973","https://openalex.org/W4378640372","https://openalex.org/W7073616627","https://openalex.org/W2288359990","https://openalex.org/W2147133240","https://openalex.org/W2485396435","https://openalex.org/W2618378037"],"abstract_inverted_index":{"Peter,":[0],"Rajesha;":[1],"Reilly,":[2],"Elizabetha;":[3],"Anthony,":[4],"SonybEditor(s):":[5],"Rees,":[6],"Alan":[7],"Author":[8],"Information":[9]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}